Russian version English version
About the Journal
Editorial Board
Instructions for Authors
Information for Readers and Authors
Current Issue
Archive
Contact Us
Search

Send manuscript
 


Volume 20   Issue 2   Year 2025
References

  1. Zhou B., Rayner A.W., Gregg E.W., Sheffer K.E., Carrillo-Larco R.M., Bennett J.E., Shaw J.E., Paciorek C.J., Singleton R.K., Barradas Pires A., et al. Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants. The Lancet. 2024;404(10467):2077–2093. doi: 10.1016/S0140-6736(24)02317-1
  2. American Diabetes Association Professional Practice Committee. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2024. Diabetes Care. 2024;47(Suppl.1):S158–S178. doi: 10.2337/dc24-S009
  3. Adler A.I., Coleman R.L., Leal J., Whiteley W.N., Clarke P., Holman R.R. Post-trial monitoring of a randomised controlled trial of intensive glycaemic control in type 2 diabetes extended from 10 years to 24 years (UKPDS 91). Lancet Lond. Engl. 2024;404(10448):145–155. doi: 10.1016/S0140-6736(24)00537-3
  4. Davies M.J., Aroda V.R., Collins B.S., Gabbay R.A., Green J., Maruthur N.M., Rosas S.E., Del Prato S., Mathieu C., Mingrone G. et al. Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2022;45(11):2753–2786. doi: 10.2337/dci22-0034
  5. Sun H., Saeedi P., Karuranga S., Pinkepank M., Ogurtsova K., Duncan B.B., Stein C., Basit A., Chan J.C.N., Mbanya J.C. et. al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res. Clin. Pract. 2022;183. Article No. 109119. doi: 10.1016/j.diabres.2021.109119
  6. Rosenfeld R.M., Grega M.L., Karlsen M.C., Abu Dabrh A.M., Aurora R.N., Bonnet J.P., Donnell L., Fitzpatrick S.L., Frates B., Joy E.A. et al. Lifestyle Interventions for Treatment and Remission of Type 2 Diabetes and Prediabetes in Adults: A Clinical Practice Guideline from the American College of Lifestyle Medicine. Am. J. Lifestyle Med. 2025;19:10S–131S. doi: 10.1177/15598276251325488
  7. Tomic D., Shaw J.E., Magliano D.J. The burden and risks of emerging complications of diabetes mellitus. Nat. Rev. Endocrinol. 2022;18(9):525–539. doi: 10.1038/s41574-022-00690-7
  8. Dedov I., Shestakova M., Mayorov A., Mokrysheva N., Andreeva E., Bezlepkina O., Peterkova V., Artemova E., Bardiugov P., Beshlieva D., et all. Standards of Specialized Diabetes Care. Diabetes Mellitus. 2023;26(2S) (in Russ.). doi: 10.14341/DM13042
  9. Saeedi P., Petersohn I., Salpea P., Malanda B., Karuranga S., Unwin N., Colagiuri S., Guariguata L., Motala A.A., Ogurtsova K. et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res. Clin. Pract. 2019;157. doi: 10.1016/j.diabres.2019.107843
  10. Kiran M., Xie Y., Anjum N., Ball G., Pierscionek B., Russell D. Machine learning and artificial intelligence in type 2 diabetes prediction: a comprehensive 33-year bibliometric and literature analysis. Front. Digit. Health. 2025;7. Article No. 1557467. doi: 10.3389/fdgth.2025.1557467
  11. Kavakiotis I., Tsave O., Salifoglou A., Maglaveras N., Vlahavas I., Chouvarda I. Machine Learning and Data Mining Methods in Diabetes Research. Comput. Struct. Biotechnol. J. 2017;15:104–116. doi: 10.1016/j.csbj.2016.12.005
  12. Knuiman M.W., Welborn T.A., Whittall D.E. An analysis of excess mortality rates for persons with non-insulin-dependent diabetes mellitus in Western Australia using the Cox proportional hazards regression model. Am. J. Epidemiol. 1992;135(6):638–648. doi: 10.1093/oxfordjournals.aje.a116343
  13. Marshall J.A. Hamman R.F., Baxter J., Mayer E.J., Fulton D.L., Orleans M., Rewers M., Jones R.H. Ethnic differences in risk factors associated with the prevalence of non-insulin-dependent diabetes mellitus. The San Luis Valley Diabetes Study. Am. J. Epidemiol. 1993;137(7):706–718. doi: 10.1093/oxfordjournals.aje.a116731
  14. Liu Q.Z., Pettitt D.J., Hanson R.L., Charles M.A., Klein R., Bennett P.H., Knowler W.C. Glycated haemoglobin, plasma glucose and diabetic retinopathy: cross-sectional and prospective analyses. Diabetologia. 1993;36(5):428–432. doi: 10.1007/BF00402279
  15. Baum A., Scarpa J., Bruzelius E., Tamler R., Basu S., Faghmous J. Targeting Weight Loss Interventions to Reduce Cardiovascular Complications of Type 2 Diabetes: A Machine Learning-Based Post-Hoc Analysis of Heterogeneous Treatment Effects in the Look AHEAD Trial. Lancet Diabetes Endocrinol. 2017;5:808–815. doi: 10.1016/S2213-8587(17)30176-6
  16. Wang J., Wang M.-Y., Wang H., Liu H.-W., Lu R., Duan T.-Q., Li C.-P., Cui Z., Liu Y.-Y., Lyu Y.-J. et al. Status of Glycosylated Hemoglobin and Prediction of Glycemic Control among Patients with Insulin-Treated Type 2 Diabetes in North China: A Multicenter Observational Study. Chin. Med. J. (Engl.). 2020;133:17–24. doi: 10.1097/CM9.0000000000000585
  17. Bernardini M., Romeo L., Misericordia P., Frontoni E. Discovering the Type 2 Diabetes in Electronic Health Records Using the Sparse Balanced Support Vector Machine. IEEE J. Biomed Health Inform. 2020;24:235–246. doi: 10.1109/JBHI.2019.2899218
  18. Lu H.Y., Lu P., Hirst J.E., Mackillop L., Clifton D.A. A Stacked Long Short-Term Memory Approach for Predictive Blood Glucose Monitoring in Women with Gestational Diabetes Mellitus. Sensors (Basel). 2023;23. Article No. 7990. doi: 10.3390/s23187990
  19. Qi X., Lu Y., Shi Y., Qi H., Ren L. A deep neural network prediction method for diabetes based on Kendall’s correlation coefficient and attention mechanism. PLoS One. 2024;19. Article No. e0306090. doi: 10.1371/journal.pone.0306090
  20. Cai L., Wu H., Li D., Zhou K., Zou F. Type 2 Diabetes Biomarkers of Human Gut Microbiota Selected via Iterative Sure Independent Screening Method. PLoS One. 2015;10. Article No. e0140827. doi: 10.1371/journal.pone.0140827
  21. Malik S., Khadgawat R., Anand S., Gupta S. Non-invasive detection of fasting blood glucose level via electrochemical measurement of saliva. SpringerPlus. 2016;5. Article No. 701. doi: 10.1186/s40064-016-2339-6
  22. Maxwell A., Li R., Yang B., Weng H., Ou A., Hong H., Zhou Z., Gong P., Zhang C. Deep learning architectures for multi-label classification of intelligent health risk prediction. BMC Bioinformatics. 2017;18. Article No. 523. doi: 10.1186/s12859-017-1898-z
  23. Dwivedi A.K. Analysis of computational intelligence techniques for diabetes mellitus prediction. Neural Comput. & Applic. 2018;30:3837–3845. doi: 10.1007/s00521-017-2969-9
  24. Nguyen B.P. Pham H.N., Tran H., Nghiem N., Nguyen Q.H., Do T.T.T., Tran C.T., Simpson C.R. Predicting the onset of type 2 diabetes using wide and deep learning with electronic health records. Comput. Methods Programs Biomed. 2019;182. Article No. 105055. doi: 10.1016/j.cmpb.2019.105055
  25. Wang T., Xuan P., Liu Z., Zhang T. Assistant diagnosis with Chinese electronic medical records based on CNN and BiLSTM with phrase-level and word-level attentions. BMC Bioinformatics. 2020;21. Article No. 230. doi: 10.1186/s12859-020-03554-x
  26. Gusev A.V., Zingerman B.V., Tyufilin D.S., Zinchenko V.V. Electronic medical records as a source of real-world clinical data. Real-World Data & Evidence. 2022;2(2):8–20 (in Russ.). doi: 10.37489/2782-3784-myrwd-13
  27. UK Biobank. https://www.ukbiobank.ac.uk (accessed: 30.06.2025).
  28. FinnGen: an expedition into genomics and medicine. https://www.finngen.fi/en (accessed: 30.06.2025).
  29. BioBank Japan. https://biobankjp.org/en/#gsc.tab=0 (accessed: 30.06.2025).
  30. All of Us Research Hub. https://allofus.nih.gov/ (accessed: 30.06.2025).
  31. Bukreeva A.S., Malsagova K.A., Petrovskiy D.V., Butkova T.V., Nakhod V.I., Rudnev V.R., Izotov A.A., Kaysheva A.L. Biobank Digitalization: From Data Acquisition to Efficient Use. Biology (Basel). 2024;13. Article No. 957. doi: 10.3390/biology13120957
  32. Xu W., Liang X., Chen L., Hong W., Hu X. Biobanks in chronic disease management: A comprehensive review of strategies, challenges, and future directions. Heliyon. 2024;10. Article No. e32063. doi: 10.1016/j.heliyon.2024.e32063
  33. Smith J.W., Everhart J.E., Dickson W.C., Knowler W.C., Johannes R.S. Using the ADAP Learning Algorithm to Forecast the Onset of Diabetes Mellitus. Proc. Annu. Symp. Comput. Appl. Med. Care. 1988:261–265.
  34. Yang Q., Bee Y.M., Lim C.C., Sabanayagam C., Yim-Lui Cheung C., Wong T.Y., Ting D.S.W., Lim L.L., Li H., He M. et al. Use of artificial intelligence with retinal imaging in screening for diabetes-associated complications: systematic review. EClinicalMedicine. 2025;81. Article No. 103089. doi: 10.1016/j.eclinm.2025.103089
  35. Zhu Z., Shi D., Guankai P., Tan Z., Shang X., Hu W., Liao H., Zhang X., Huang Y., Yu H. et al. Retinal age gap as a predictive biomarker for mortality risk. Br. J. Ophthalmol. 2023;107:547–554. doi: 10.1136/bjophthalmol-2021-319807
  36. Betzler B.K., Chee E.Y.L., He F., Lim C.C., Ho J., Hamzah H., Tan N.C., Liew G., McKay G.J., Hogg R.E. et al. Deep learning algorithms to detect diabetic kidney disease from retinal photographs in multiethnic populations with diabetes. J. Am. Med. Inform. Assoc. 2023;30(12):1904–1914. doi: 10.1093/jamia/ocad179
  37. Ma Y., Xiong J., Zhu Y., Ge Z., Hua R., Fu M., Li C., Wang B., Dong L., Zhao X. et al. Deep learning algorithm using fundus photographs for 10-year risk assessment of ischemic cardiovascular diseases in China. Sci. Bull. 2022;67(1):17–20. doi: 10.1016/j.scib.2021.08.016.
  38. Rönn T., Perfilyev A., Oskolkov N., Ling C. Predicting type 2 diabetes via machine learning integration of multiple omics from human pancreatic islets. Sci. Rep. 2024;14(1). Article No. 14637. doi: 10.1038/s41598-024-64846-3
  39. Cerezo M., Sollis E., Ji Y., Lewis E., Abid A., Bircan K.O., Hall P., Hayhurst J., John S., Mosaku A. et al. The NHGRI-EBI GWAS Catalog: standards for reusability, sustainability and diversity. Nucleic Acids Res. 2025;53:D998–D1005. doi: 10.1093/nar/gkae1070.
  40. Costanzo M.C., von Grotthuss M., Massung J., Jang D., Caulkins L., Koesterer R., Gilbert C., Welch R.P., Kudtarkar P., Hoang Q. et al. The Type 2 Diabetes Knowledge Portal: An open access genetic resource dedicated to type 2 diabetes and related traits. Cell Metab. 2023;35(4):695–710.e6. doi: 10.1016/j.cmet.2023.03.001
  41. Deutsch E.W., Bandeira N., Perez-Riverol Y., Sharma V., Carver J.J., Mendoza L., Kundu D.J., Wang S., Bandla C., Kamatchinathan S. et al. The ProteomeXchange consortium at 10 years: 2023 update. Nucleic Acids Res. 2023;51:D1539–D1548. doi: 10.1093/nar/gkac1040
  42. Perez-Riverol Y., Bandla C., Kundu D.J., Kamatchinathan S., Bai J., Hewapathirana S., John N.S., Prakash A., Walzer M., Wang S. et al. The PRIDE database at 20 years: 2025 update. Nucleic Acids Res. 2025;53:D543–D553. doi: 10.1093/nar/gkae1011
  43. Yurekten O., Payne T., Tejera N., Amaladoss F.X., Martin C., Williams M., O'Donovan C. MetaboLights: open data repository for metabolomics. Nucleic Acids Res. 2023;52:D640–D646. doi: 10.1093/nar/gkad1045
  44. Wishart D.S., Guo A., Oler E., Wang F., Anjum A., Peters H., Dizon R., Sayeeda Z., Tian S., Lee B.L. et al. HMDB 5.0: the Human Metabolome Database for 2022. Nucleic Acids Res. 2022;50:D622–D631. doi: 10.1093/nar/gkab1062
  45. Khan H., Ali K., Aslam A., Singla D., Aman I. Progress in the management of type 2 diabetes mellitus: a narrative review of telerehabilitation and wearable devices. Ann. Pediatr. Endocrinol. Metab. 2025;30(2):69–76. doi: 10.6065/apem.2448162.081
  46. Casas L.A., Alarcón J., Urbano A., Peña-Zárate E.E., Sangiovanni S., Libreros-Peña L., Escobar M.F. Telemedicine for the management of diabetic patients in a high-complexity Latin American hospital. BMC Health Serv. Res. 2023;23(1). Article No. 314. doi: 10.1186/s12913-023-09267-0
  47. Årsand E., Frøisland D.H., Skrøvseth S.O., Chomutare T., Tatara N., Hartvigsen, G., Tufano J.T. Mobile Health Applications to Assist Patients with Diabetes: Lessons Learned and Design Implications. J. Diabetes Sci. Technol. 2012;6:1197–1206. doi: 10.1177/193229681200600525
  48. Starostina E.G., Volodina M.N., Starostin I.V., Bobrov A.E. Depression and diabetes mellitus as comorbid disorders. RMJ. 2017;22:1613–1620 (in Russ.).
  49. Schmitt A., Gahr A., Hermanns N., Kulzer B., Huber J., Haak T. The Diabetes Self-Management Questionnaire (DSMQ): development and evaluation of an instrument to assess diabetes self-care activities associated with glycaemic control. Health Qual. Life Outcomes. 2013;11. Article No. 138. doi: 10.1186/1477-7525-11-138
  50. Bujang M.A., Adnan T.H., Mohd Hatta N.K.B., Ismail M., Lim C.J. A Revised Version of Diabetes Quality of Life Instrument Maintaining Domains for Satisfaction, Impact, and Worry. J. Diabetes Res. 2018;2018. Article No. 5804687. doi: 10.1155/2018/5804687
  51. Problem Areas In Diabetes Scale (PAID). https://professional.diabetes.org/sites/default/files/media/ada_mental_health_toolkit_questionnaires.pdf (accessed: 30.06.2025).
  52. Diabetes Distress Scale (DDS). https://www.mdcalc.com/calc/10523/diabetes-distress-scale-dds17 (accessed: 30.06.2025).
  53. Bernabe-Ortiz A., Perel P., Miranda J.J., Smeeth L. Diagnostic accuracy of the Finnish Diabetes Risk Score (FINDRISC) for undiagnosed T2DM in Peruvian population. Prim. Care Diabetes. 2018;12(6):517–525. doi: 10.1016/j.pcd.2018.07.015
  54. Meijer J.W.G., Smit A.J., Sonderen E.V., Groothoff J.W., Eisma W.H., Links T.P. Symptom scoring systems to diagnose distal polyneuropathy in diabetes: the Diabetic Neuropathy Symptom score. Diabet. Med. 2002;19(11):962–965. doi: 10.1046/j.1464-5491.2002.00819.x
  55. Yang Z., Chen R., Zhang Y., Huang Y., Hong T., Sun F., Ji L., Zhan S. Scoring systems to screen for diabetic peripheral neuropathy. Cochrane Database Syst. Rev. 2018;2018(7). Article No. CD010974. doi: 10.1002/14651858.CD010974
  56. Iftikhar M., Saqib M., Qayyum S.N., Asmat R., Mumtaz H., Rehan M., Ullah I., Ud-Din I., Noori S., Khan M. et al. Artificial intelligence-driven transformations in diabetes care: a comprehensive literature review. Ann. Med. Surg. 2024;86(9):5334–5342. doi: 10.1097/MS9.0000000000002369
  57. Oikonomou1 E.K., Khera1 R. Machine learning in precision diabetes care and cardiovascular risk prediction. Cardiovascular Diabetology. 2023;22. Article No. 259 doi: 10.1186/s12933-023-01985-3
  58. Corrao S., Janić M., Maggio V., Rizzo M. Machine learning and deep learning in diabetology: revolutionizing diabetes care. Front. Clin. Diabetes Healthc. 2025;6. Article No. 1547689. doi: 10.3389/fcdhc.2025.1547689
  59. Darwich A.S., Polasek T.M., Aronson J.K., Ogungbenro K., Wright D.F.B., Achour B., Reny J.L., Daali Y., Eiermann B., Cook J. et al. Model-Informed Precision Dosing: Background, Requirements, Validation, Implementation, and Forward Trajectory of Individualizing Drug Therapy. Annu. Rev. Pharmacol. Toxicol. 2021;61:225–245. doi: 10.1146/annurev-pharmtox-033020-113257
  60. Emerson H., Guy M., McConville R. Offline reinforcement learning for safer blood glucose control in people with type 1 diabetes. J. Biomed. Inform. 2023;142. Article No. 104376. doi: 10.1016/j.jbi.2023.104376
  61. Alsadoun L., Ali H., Mushtaq M., Mushtaq M., Burhanuddin M., Anwar R., Liaqat M., Bokhari S.F.H., Hasan A.H., Ahmed F. et al. Artificial Intelligence (AI)-Enhanced Detection of Diabetic Retinopathy from Fundus Images: The Current Landscape and Future Directions. Cureus. 2024;16(8). Article No. e67844. doi: 10.7759/cureus.67844
Table of Contents
Original Article
Butkova T.V., Kulikova L.I., Malsagova K.A., Petrovskiy D.V., Rudnev V.R., Ryskina E.A., Kulikov A.V., Kaysheva A.L. Modern Machine Learning Approaches for Predicting Type 2 Diabetes Mellitus. Ìàthematical biology and bioinformatics. 2025;20(2):301-319. doi: 10.17537/2025.20.301
(published in Russian)

Abstract (rus.)
Abstract (eng.)
Full text (rus., pdf)
References

 
  Copyright IMPB RAS © 2005-2026